Renal Denervation

This channel includes news and new technology innovations for renal denervation used to treat hypertension. Renal denervation is a catheter-based therapy. The catheter is into the renal artery and delivers radio-frequency energy to ablate the nerves in the vessel wall that regulate vasoconstriction. This leaves the vessel permanently in the widest open position to allow greater blood flow to the kidneys. This enables greater filtration of the blood and removal of excess water that causes hypertension

MEDTRONIC, symplicity renal denervation catheter

The Medtronic Symplicity catheter was the first renal denervation system to prove in clinical trials the therapy can lower drug-resistant hypertension.

Feature | July 30, 2013 | Dave Fornell

One of the exciting new frontiers for interventional cardiology is the use of renal denervation therapy to treat...

FDA US device innovation

The delay in being able to bring new medical device advances to market in the United States, such as transcatheter aortic valves and left atrial appendage occluders, has raised the question of the U.S. leadership role in technology innovation.

Feature | July 03, 2013 | Anita Asgar, M.D., FSCAI

The field of interventional cardiology is one of constant change and innovation. The past 10 years have...

News | June 13, 2013

June 13, 2013 — St. Jude Medical Inc. announced U.S. Food and Drug Administration (FDA) approval to begin the...

Boston Scientific Vessix Renal Denervation System Hypertension Therapies
News | June 06, 2013

June 6, 2013 — Boston Scientific Corporation reported interim data from the REDUCE-HTN...

News | June 03, 2013

June 3, 2013 — St. Jude Medical Inc. announced that the company’s EnligHTN multi-electrode renal denervation system ...

News | May 30, 2013

May 30, 2013 — Kona Medical announced three and six month results from the WAVE I study, a first-in-man study...

News | May 17, 2013

May 17, 2013 — Can high blood pressure be safely reduced and controlled by “disconnecting” nerves in the kidneys?...

News | April 24, 2013

April 24, 2013 — Cardiosonic Inc. announced the completion of the first phase of patient enrollment in its first-in-...

Feature | April 01, 2013

April 1, 2013 — Rox Medical announced enrollment of the first U.K. patients in the CONTROL-HTN international...

Symplicity Renal Denervation System Medtronic Inc. Parallel Review Program
Feature | March 12, 2013

March 12, 2013 — Medtronic Inc. announced the U.S. Food and Drug Administration (FDA) and the Centers for Medicare...

Renal Denervation Clinical Study EnligHTNment Trial St. Jude Medical
Feature | March 01, 2013

March 1, 2013 — St. Jude Medical Inc. announced plans for a new landmark...

St. Jude Medical EnligHTN II trial Renal Denervation System
Feature | February 13, 2013

February 13, 2013 — St. Jude Medical Inc. announced enrollment of the first patient in the EnligHTN II trial. This...

Feature | February 04, 2013 | Dave Fornell

My job as editor of DAIC is to help readers keep tabs on the latest in cardiovascular technology and trends. With...

Blog | February 04, 2013

My job as editor of DAIC is to help readers keep tabs on the latest in cardiovascular technology and trends. With...

Top stories of 2012 in cardiology
Feature | January 29, 2013 | Dave Fornell

To help identify trends and find out what DAIC readers are interested in, the magazine takes note of what they click...

Overlay Init